1. U.S. Food and Drug Administration. Digital health technologies for remote data acquisition in clinical investigations. Guidance for industry investigators and other stakeholders. 2023 [cited 2024 Jun 27]. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/digital-health-technologies-remote-data-acquisition-clinical-investigations
2. U.S. Food and Drug Administration. Decentralized clinical trials for drugs biological products and devices guidance for industry investigators and other stakeholders DRAFT GUIDANCE. 2023. Available from: https://www.fda.gov/vaccines-blood-biologics/guidance-compliance-regulatory-information-biologics/biologics-guidances
3. Clinical Trials Transformation Initiative. Framework of specifications to consider during digital health technology selection specification definition considerations associated recommendations [Internet]. 2021 [cited 2024 Apr 13]. Available from: https://ctti-clinicaltrials.org/topics/mobile/selecting-a-mobile-technology/table-1-framework-of-specifications-to-consider-during-digital-health-technology-selection/
4. Verification, analytical validation, and clinical validation (V3): the foundation of determining fit-for-purpose for Biometric Monitoring Technologies (BioMeTs)
5. Digital Medicine Society. The V3+ Usability Validation Glossary [Internet]. [cited 2024 Apr 14]. Available from: https://datacc.dimesociety.org/resources/v3-usability-validation-glossary/